Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

Trial Profile

Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amlodipine (Primary) ; Doxazosin (Primary) ; Lisinopril (Primary) ; ACE inhibitors; Antihypertensives; Chlortalidone; Diuretics; Pravastatin
  • Indications Atrial fibrillation; Cardiovascular disorders; Heart failure; Hyperlipidaemia; Hypertension; Stroke
  • Focus Therapeutic Use
  • Acronyms ALLHAT
  • Most Recent Events

    • 18 Nov 2019 Results (n=29892) of a causal mediation analysis assessing mechanism of Heart failure in patients treated for Hypertension were presented at the American Heart Association Scientific Sessions 2019
    • 08 Feb 2012 Planned End Date changed from 1 Mar 2008 to 1 Mar 2002.
    • 01 Jan 2012 Results published in the Journal of Clinical Hypertension (Greenwich).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top